Cosmo Pharmaceuticals NV banner

Company Overview

Business Description

Sector
Health Care
Industry
Pharmaceuticals
Headquarters
Ireland IE
Employees
325
IPO date
May 18, 2016

Cosmo Pharmaceuticals is a specialty drug company focused on digestive health and endoscopy. It develops medicines and medical products used to treat gastrointestinal conditions and to help doctors inspect and treat the colon and other parts of the digestive tract. Its products are aimed mainly at hospitals, gastroenterologists, and sometimes pharmacies, depending on the product and market.

The company makes money by selling its own branded products and by licensing or partnering around medicines and device-related products in its field. In practice, that means it may earn revenue from product sales, supply agreements, and payments tied to commercial partnerships. This gives it a mix of direct sales and collaboration-based income.

What makes Cosmo different is its tight focus on a narrow area of medicine rather than broad healthcare. It sits in the middle of the value chain: it develops or in-licenses products, works through regulators and clinical testing, and then sells them to doctors, hospitals, or larger drugmakers that help reach the market. That specialty focus makes it easier to build expertise in a few high-need treatment areas.

Cosmo Pharmaceuticals NV Investor Relations

Address
Riverside II, Sir John Rogerson's Quay, Dublin 2
Dublin
Ireland

Business Segments

Pharmaceuticals

This part develops and markets prescription medicines for gastrointestinal and skin conditions, and it also supports late-stage drug development work tied to those products.

Customers and revenue model

Medical devices

This part makes and sells endoscopy technology, including AI-assisted tools used during colonoscopy to help doctors spot problems more reliably.

Customers and revenue model

Management

Mr. Alessandro E. Della Cha LL.M

Executive Chairman

Biography unavailable

Mr. Niall Donnelly

Executive VP of Corporate Governance, Chief Sustainability Officer & Executive Director

Biography unavailable

Mr. Giovanni Di Napoli

Chief Executive Officer & Director

Biography unavailable

Mr. Mauro Severino Ajani

Founder & Non-Executive Director

Biography unavailable

Ms. Svetlana Sigalova

Chief Financial Officer

Biography unavailable

Mr. Marco Lecchi

Chief Operating Officer

Biography unavailable

Mr. Davide Malavasi

Qualified Person & Technical Director

Biography unavailable

Mr. Luigi Longo

Chief Scientific Officer

Biography unavailable

Ms. Hazel Winchester

Head of Investor Relations

Biography unavailable

Mr. Biagio Vigano

Chief People Officer

Biography unavailable

1 / 10